Clinical Trials

HIV/AIDS
A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed (SOLAR)
- Ages18 years and older
- GenderBoth
Liver, HIV/AIDS, Infectious Disease
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
- Ages18 years and older
- GenderBoth
HIV/AIDS
Mechanisms of HIV latency
- Ages18 years and older
- GenderBoth